An Open Label Study to Assess the Safety and Efficacy of MBM-01 for the Treatment of Ataxia Telangiectasia
Latest Information Update: 08 May 2023
At a glance
- Drugs Tempol (Primary)
- Indications Ataxia telangiectasia
- Focus Therapeutic Use
- Sponsors Matrix Biomed
- 18 May 2021 New trial record